Stanford University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).
Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.
Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.
Top-decile sponsor footprint
Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,744 total, page 33 of 35
Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy
NCT01078350
A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer
NCT00238628
Understanding the Genetic Basis of Atherosclerosis and Peripheral Arterial Disease
NCT00380185
BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)
NCT00186329
Magnesium Sulfate vs Placebo for Placental Abruption
NCT00186069
An Interactive Program to Improve Care for Children With CF
NCT00185549
Study to Promote Physical Activity Among Overweight Persons
NCT00313040
Mothers With a History of Depression and Their 10-14 Year Old Daughters
NCT01129752
Behavioral Maintenance Treatment for Smoking Cessation
NCT01615770
Memantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major Depression
NCT00186498
Healthier Living With Arthritis Online Program
NCT00398255
Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer
NCT00568360
A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy Patients
NCT00568698
Depakote ER in Bipolar Depression
NCT00186186
Reproductive Function and Mood in Women With Bipolar Disorder
NCT00183352
A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients
NCT00568802
Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia
NCT00160329
Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases
NCT00185874
Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease.
NCT00240019
Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma
NCT00185861
Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer
NCT00186277
Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer
NCT00532987
Impact of Treatment Induced Premature Menopause on Quality of Life
NCT00185718
Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma
NCT00186355
Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation
NCT00185887
Evaluation of Stereotactic Radiosurgery For Liver Malignancies
NCT00230347
Comparing Two Group Therapy Treatments for Binge Eating Disorder
NCT00071578
Genetics of Symptomatology and Treatment Response in Psychotic Major Depression
NCT00691535
Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA
NCT00394615
Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.
NCT00186537
Antibiotics for Postpartum Third and Fourth Degree Perineal Tear Repairs
NCT00186082
The Use of Prophylactic Antibiotics In the Management of Dog Bites
NCT00185939
Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT)
NCT00855647
Estrogen Use in Protection From Cognitive Decline
NCT00097058
Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation
NCT00186420
Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer
NCT00233415
Acute Treatment of Bipolar II Depression
NCT00074776
A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal
NCT00523185
The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers
NCT00230269
Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression
NCT00186485
Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells
NCT00186316
Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers
NCT00230256
Reducing Risk and Trauma-Related Stress in Persons Living With HIV
NCT00186030
Comparative Renal Function of Young (18-45 Years) and Ageing (55 Years and Above) Kidney Donors
NCT00846729
Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies
NCT00185640
Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults
NCT00352287
Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer
NCT00226954
Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC
NCT00238615
Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast
NCT00230295
Mifepristone in Refractory Depression
NCT00186056
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 209 |
| Phase 3 | 51 |
| Phase 4 | 86 |
Therapeutic Areas
What is open in the Stanford University pipeline
264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).
Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.